Jan Nilsson
Director/Board Member at CanImGuide Therapeutics AB
Jan Nilsson active positions
| Companies | Position | Start | End |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - | - |
| Urbicum Ledningskonsult AB | Director/Board Member | - | - |
Panion Animal Health AB
 Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Director/Board Member | 2019-08-19 | - |
CarryGenes Therapeutics AB
 CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Director/Board Member | - | - |
| Immodulate Pharma AB | Director/Board Member | - | - |
Career history of Jan Nilsson
Former positions of Jan Nilsson
| Companies | Position | Start | End |
|---|---|---|---|
| COMBIGENE AB | Director/Board Member | 2019-12-31 | - |
| Chief Executive Officer | 2016-09-30 | 2023-08-31 | |
| Investor Relations Contact | 2016-09-30 | 2023-08-31 | |
| Neurovive Pharmaceutical AB | Chief Executive Officer | 2013-01-31 | 2016-08-31 |
| ABLIVA AB | Director/Board Member | 2009-12-31 | 2015-08-31 |
| Chief Executive Officer | 2015-08-31 | 2016-03-13 | |
| Chief Operating Officer | 2009-12-31 | 2016-08-23 | |
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Director/Board Member | 2010-12-31 | 2012-12-31 |
| Chief Executive Officer | 2010-12-31 | 2012-12-31 | |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Training of Jan Nilsson
| University of Gothenburg | Graduate Degree |
| University of Uppsala | Masters Business Admin |
Statistics
International
| Sweden | 13 |
Operational
| Director/Board Member | 8 |
| Chief Executive Officer | 4 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ABLIVA AB | Health Technology |
| COMBIGENE AB | Health Technology |
| Private companies | 8 |
|---|---|
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Pergamum AB
 Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
| Urbicum Ledningskonsult AB | |
Panion Animal Health AB
Panion Animal Health AB Agricultural Commodities/MillingProcess Industries Panion Animal Health AB engages in the development and commercialization of gene-therapeutic treatment of epileptic-type disorders in dogs and other animals. It specializes in combining modern neuroscience with recent advances in gene delivery. The company was founded in July 2015 and is headquartered in Hassleholm, Sweden. | Process Industries |
CarryGenes Therapeutics AB
CarryGenes Therapeutics AB Miscellaneous Commercial ServicesCommercial Services CarryGenes Therapeutics AB engages in the research and development of biotechnology. The private company is based in Stockholm, Sweden. | Commercial Services |
| Immodulate Pharma AB | |
| Neurovive Pharmaceutical AB |
- Stock Market
- Insiders
- Jan Nilsson
- Experience
